Vertex Pharmaceuticals Inc. (VRTX) — Insider Trading

Sector: Healthcare â€ĸ All Insider Transactions

🔄 Last update: 11/17/2026 at 14:20 UTC
Sales (90d)
$14.7M
2 transactions
Buys (90d)
$0
0 transactions
WhaleSentiment Score â„šī¸
âšĒ +0
Neutro
Form 144 Filings
4
Upcoming sale notices

Stock Price VRTX 📉

VRTX stock price — last 6 months

Last Price
$537.79
16/11/2026 (market close)
Daily Change
-0.81 (-0.15%)
6-Month Performance
+23.2%
$436.58 → $537.79
6M High / 6M Low
$558.88
Min: $425.09
$425$459$492$525$559 2026-05-182026-08-182026-11-16 SELL 2026-11-12SELL 2026-11-06Insider Sell (2)

▲ = insider buy (0), â–ŧ = insider sell (2)

Data from Yahoo Finance, 15-min delay. Last update: 16/11/2026 (market close).

All Insider Transactions VRTX — 2026

Insider Transactions

Date Insider Role Type Shares Price Value
11/12/2026 WAGNER CHARLES F JR EVP, CO & FO Sale 15,286 $547.87 $8.4M
11/06/2026 Kewalramani Reshma CEO & President Sale 11,866 $531.53 $6.3M
10/20/2026 Brennan Daniel J. Director Award 795 $503.47 $0.4M
10/15/2026 SACHS BRUCE I Director Award 92 $512.44 $0.05M
10/15/2026 Garber Alan M Director Award 29 $512.44 $0.02M
09/08/2026 van Grunsven Jasper EVP, CP and NPPO Award 8,682 — —
08/28/2026 Ambrose Kristen SVP & Chief Accounting Officer Award 5,000 — —
08/27/2026 SACHS BRUCE I Director Gift 6,000 — —

Holdings Summary

InsiderRoleShares HeldLast Transaction
Kewalramani Reshma CEO & President 86,471 11/06/2026
WAGNER CHARLES F JR EVP, CO & FO 31,764 11/12/2026
SACHS BRUCE I Director 15,864 10/15/2026
Ambrose Kristen SVP & Chief Accounting Officer 11,624 08/28/2026
van Grunsven Jasper EVP, CP and NPPO 8,682 09/08/2026
Brennan Daniel J. Director 795 10/20/2026
Garber Alan M Director 94 10/15/2026

âš ī¸ Form 144 — Upcoming Sale Notices

Form 144 is filed BEFORE the actual sale. It is an important leading indicator.

Filing DateTypeSEC Link
11/16/2026 144 View Filing →
11/16/2026 144 View Filing →
11/12/2026 144 View Filing →
11/06/2026 144 View Filing →

Financial Context

Recent financial data from SEC filings (XBRL) to contextualize insider activity.

Revenue (latest quarter)
$640.8M
Period: 2018-03-31
Net Income
$653.6M
Profit
Diluted EPS
$2.56
Per share

What is Insider Trading on Vertex Pharmaceuticals Inc.?

Legal insider trading occurs when executives, directors, and major shareholders (>10%) of a public company buy or sell shares of their own company and report it to the SEC via Form 4.

How to Read the Data

Open market purchases (P) — the strongest signal. The insider uses their own money to buy shares.

Signals to Watch for VRTX

Sources & References

All data on this page comes directly from public SEC filings.

📋 View all Form 4 filings on SEC EDGAR VRTX →

Insider Trading — Healthcare Sector

Other Healthcare stocks with monitored insider activity:

đŸ”Ĩ Most Active Stocks — Insider Trading

Stocks with the highest number of recent insider transactions:

📚 Related Resources

âš ī¸ Disclaimer: WhaleSentiment provides public SEC data for informational and educational purposes only. It does not provide financial advice, investment recommendations, or solicitation to buy/sell financial instruments. Always consult a qualified financial advisor before making investment decisions.